Sufaxin is a common misspelling of Surfaxin (lucinactant).
What is Surfaxin (Sufaxin)?
The most common side effects associated with the use of Surfaxin (Sufaxin) are endotracheal tube reflux, pallor and endotracheal tube obstruction.
During Surfaxin (Sufaxin) use administration should be stopped if bradycardia, oxygen desaturation, endotracheal tube reflux, or airway obstruction occurs. The infantâ€™s clinical condition should then be assessed and stabilized. Surfaxin (Sufaxin) is not indicated for use in acute respiratory distress syndrome (ARDS).
Click for more information on Sufaxin (Surfaxin)
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.